Skip to main content
IMRX filings

Corporate insider profile

Benjamin J. Zeskind Filing Activity

Latest reported as PRESIDENT AND CEO of Immuneering Corp (IMRX).

Purchase filings
1
Reported companies
1
Net open-market value
$10,948
Latest transaction
Jun 23, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 23, 2026Immuneering Corp (IMRX)PRESIDENT AND CEOOpen Market Purchase2,400$4.56$10,948